A fixed-dose combination of two endogenous mitochondrial cofactors. Coenzyme Q10 (Ubidecarenone) is a fat-soluble, vitamin-like benzoquinone essential for mitochondrial ATP synthesis and acts as a potent antioxidant. Levo-carnitine (L-carnitine) is a quaternary ammonium compound crucial for the transport of long-chain fatty acids into the mitochondrial matrix for beta-oxidation. This combination is primarily used as a metabolic enhancer and cardioprotective supplement, especially in conditions of energy deficit and oxidative stress.
Adult: One capsule/tablet once or twice daily, preferably with meals containing fats to enhance CoQ10 absorption. Typical dose: CoQ10 30-60mg, L-Carnitine 500-1000mg per day in divided doses.
Note: Administer with or immediately after a meal, preferably containing some dietary fat (e.g., nuts, oil, avocado) to significantly improve the bioavailability of CoQ10. Swallow the capsule/tablet whole with a full glass of water. Do not crush or chew.
The combination synergistically supports cellular energy (ATP) production and mitigates oxidative damage. CoQ10 acts as an electron carrier in the mitochondrial electron transport chain (Complexes I, II, and III) and is a lipid-soluble antioxidant regenerating vitamin E. L-Carnitine is essential for transporting activated long-chain fatty acids (acyl-CoA) across the inner mitochondrial membrane as acylcarnitine esters for beta-oxidation. Together, they optimize mitochondrial function, improve myocardial efficiency, and reduce cytotoxic effects of accumulated acyl-CoA intermediates.
Pregnancy: Category C (US FDA). Safety not established. CoQ10 and L-Carnitine are naturally present. Use only if potential benefit justifies potential risk to the fetus, under obstetrician guidance. Limited data from studies in pre-eclampsia.
Driving: Unlikely to impair ability. However, be cautious if dizziness or hypotension occurs, especially at initiation of therapy.
| Warfarin and other Vitamin K Antagonists | CoQ10 has structural similarity to vitamin K2; may theoretically reduce anticoagulant effect. Clinical significance debated but monitor INR closely. | Moderate |
| Beta-blockers (e.g., Propranolol, Metoprolol) | May inhibit the endogenous synthesis of CoQ10. The supplement may help mitigate associated fatigue. | Mild |
| Statins (Atorvastatin, Simvastatin, etc.) | Statins inhibit HMG-CoA reductase, depleting endogenous CoQ10. This combination is used to treat statin-induced myopathy. | Mild (Beneficial) |
| Blood Pressure Lowering Drugs | Additive hypotensive effect; monitor BP, especially with alpha-blockers, ACE inhibitors, and diuretics. | Moderate |
| Insulin & Oral Hypoglycemics (Sulfonylureas, Metformin) | L-Carnitine may enhance insulin sensitivity and increase risk of hypoglycemia. Monitor blood glucose levels. | Moderate |
| Thyroid Hormones (Levothyroxine) | CoQ10 may enhance thyroid hormone action. Monitor thyroid function tests. | Mild |
Same composition (Coenzyme Q10 (30mg) + Levo-carnitine (500mg)), different brands: